HYDERABAD: It and Industries Minister KT Rama Rao on Monday introduced that the State authorities is partnering with US-based Cytiva to create a B-Hub (Biopharma Hub) so as to develop biopharmaceutical medicines. Giving an outline of the way forward for Hyderabad’s life sciences sector, whereas presenting the Genome Valley Excellence Award to Bharat Biotech, he stated: “The State authorities is partnering with Cytiva to set up a biopharma scale up facility referred to as B-Hub.
As you all know that eight of the ten high promoting medicines are biopharmaceuticals.”“While there exist formidable capabilities in chemical drugs in the country, B-Hub will help Telangana and India in accelerating in this sector,” he added.
‘Life sciences attracted Rs 3,700 cr investments’
While highlighting Hyderabad’s contribution to the life sciences sector, Rama Rao additionally stated that Hyderabad-based Aurobindo Pharma is constructing a vaccine facility within the metropolis which shall be in a position to manufacture 450 million doses yearly.“Life sciences sector has attracted investments of up to Rs 3,700 crore, creating employment opportunities for 17,000 people,” he stated.
“Hyderabad-based Sai Life Sciences inaugurated its new facility in Genome Valley with an investment of Rs 400 core. The new campus will play a pivotal role in discovery of new drugs,” he added.He additionally knowledgeable that Syngene, whose campus was inaugurated final yr throughout BioAsia, has elevated its work power from 100 to 225 and can quickly lease its third constructing.
“GVK Bio is also expanding rapidly and will add 600 new jobs in Hyderabad. Further, Granules India will also be investing Rs 400 crore in its new facility with a capacity to produce 10 billion units of finished doses,” the Minister stated. He additional added that Switzerland-based Ferring Pharmaceuticals began their operations final yr, and Canada-based Jamp Pharma’s facility can be inaugurated subsequent month.
Rama Rao additionally stated the State authorities can also be trying to additional the medical gadgets sector and there are 40 corporations within the MedTech Park in Rangareddy district. “We are also working on Digital Medicine Hub, Institute for Cell and Gene Therapy, Flow Chemistry Hub and so on,” he added. While accepting the award, Bharat Biotech Managing Director Krishna Ella stated 65 per cent of the Indian vaccine market is produced in Hyderabad. “In future, vaccines for pandemic will come only from Hyderabad. No other city produces around 65 per cent vaccine of the market,” he stated.